Summary

Global Sleep Apnea Devices Market Size

Sleep Apnea Devices market is expected to reach US$ 12.23 billion by 2033 from US$ 6.47 billion in 2024, with a CAGR of 7.32% from 2025 to 2033. Among other contributing reasons, the growing prevalence of sleep apnea and associated comorbidities, growing awareness of sleep apnea and sleep disorders, and the aging population's increased need are all responsible for the market's strong rise.


Sleep Apnea Devices Industry Overview

Because of the rising incidence of sleep apnea diseases, especially obstructive sleep apnea (OSA), and increased awareness of the problem, the market for sleep apnea devices is expanding significantly. Millions of individuals worldwide suffer from sleep apnea, and as more people become aware of the health dangers it poses, including those to diabetes, stroke, and cardiovascular disease, there is a growing need for efficient treatment options. Continuous Positive Airway Pressure (CPAP) machines, BiPAP (Bilevel Positive Airway Pressure) machines, automatic CPAP machines, oral appliances, and adaptive servo-ventilation (ASV) devices are only a few of the many devices available in the market. Although CPAP is still the gold standard for treating OSA, technological developments have produced smaller, more comfortable, and quieter devices that increase patient compliance.

Technological advancements that improve patient management and therapy customization, like mobile apps for sleep monitoring, connected devices, and portable home sleep testing, are driving the market. Increased accessibility and uptake have also been facilitated by the growth of e-commerce platforms and the expanding availability of sleep apnea devices in home healthcare settings. Notwithstanding these encouraging developments, the business still confronts obstacles such as the high expense of care, restricted insurance coverage in some areas, and problems with device adherence brought on by discomfort or loudness. However, in the upcoming years, the market is anticipated to continue expanding due to the rising demand for home-based therapies and rising healthcare expenditures on sleep apnea treatment.

According to data released by the National Center for Biotechnology Information (NCBI) in 2023, for example, there are 425 million people with moderate to severe OSA and about 936 million people with mild to severe OSA worldwide.


Growth Drivers for the Sleep Apnea Devices Market

Increasing Patient Adoption of Cutting-Edge Sleep Apnea Management Devices

The development of new options for managing sleep apnea has been greatly aided by the growing preference for technologically sophisticated gadgets. Among other things, patient comfort is one of the reasons why oral devices like the mandibular advancement device (MAD) are becoming more and more popular for treating OSA. Additionally, as the market grows, major manufacturers are introducing novel oral appliances that have been shown to be successful and provide patients with comfort while they treat the condition.

To meet the increasing needs of patients with obstructive sleep apnea (OSA), the U.S. FDA, for example, approved a novel mandibular repositioning device called AIO BREATHE in February 2024. This and the actometer, a portable diagnostic tool, are both becoming more and more popular for a variety of reasons, such as their affordability and non-invasiveness. Thus, the increasing need for affordable sleep apnea diagnostic tools is supporting patients' preference for actometers and oral appliances for successful sleep apnea treatment.


Growing Obstructive Sleep Apnea Prevalence Will Increase Device Demand

increasing rates of obstructive sleep apnea in patients as a result of a number of causes, such as obesity, high levels of stress, poor sleep habits, and sedentary lifestyles. An estimated 39 million adults in the United States suffer with obstructive sleep apnea, according to a 2023 article published by the National Council on Aging (NCOA).

For example, according to the American Heart Association article, multiple cross-sectional studies have suggested that 70% of OSA patients are fat, and 40% of the obese population has substantial sleep apnea. Additionally, data from the European Respiratory Society showed that between 13.0% and 32.0% of Europe's elderly population had sleep apnea.

Patients are receiving more treatment as a result of the expanding diagnosis rate, which is further supported by the rising prevalence of obesity and other lifestyle disorders as well as rising healthcare costs. This is contributing to the increasing market uptake of these devices, as does the expansion of sleep clinics and technicians. Another element anticipated to support market expansion is the expansion of strategic initiatives and educational activities aimed at boosting public knowledge of the situation.


Increasing Awareness and Diagnosis

The market is expanding due in large part to rising awareness and diagnosis of sleep apnea. The need for sleep apnea diagnosis and treatment is rising as more people become aware of the dangers of untreated sleep apnea, including heart disease, diabetes, and stroke. Media coverage, healthcare professional education, and public awareness initiatives have all been crucial in educating people about the value of early detection. Patients are finding it easier to receive a diagnosis because to improved diagnostic techniques such sophisticated polysomnography and at-home sleep studies. More people are seeking evaluation as global healthcare systems increase their emphasis on sleep health, which raises the diagnostic rate. The market for sleep apnea devices is developing as a result of the increased awareness of the problem, which is de-stigmatizing it and promoting early therapies.


Challenges in the Sleep Apnea Devices Market

Patient Compliance and Adherence

With CPAP therapy, the most popular treatment for obstructive sleep apnea, patient compliance and adherence continue to be major obstacles in the market for sleep apnea devices. Because of discomfort, noise, air pressure, and mask fit difficulties, many patients find it difficult to use their devices on a regular basis. Low adherence rates brought on by these obstacles may lessen the efficacy of treatment and perhaps harm health consequences. Because of this, many people stop taking their medication even if it has been shown to be beneficial, which raises their chance of developing heart disease, stroke, and other problems. Manufacturers are concentrating on creating devices that are more comfortable, quiet, and easy to use in order to increase compliance. Furthermore, adherence can be improved by patient education, ongoing monitoring, and support via telemedicine and mobile apps, which will help patients better manage their conditions over the long run.


Competition from Alternative Therapies

The market for sleep apnea equipment is challenged by competition from alternative therapies. Even though CPAP therapy is still the most effective treatment for obstructive sleep apnea, many patients look for alternatives because they are uncomfortable or inconvenient. Patients who cannot tolerate CPAP may find oral appliances, such as mandibular advancement devices (MADs), to be an appealing alternative because they provide a non-invasive treatment for mild to moderate instances of sleep apnea. Positional therapy, which promotes specific sleeping positions for patients in order to avoid airway blockage, is also becoming more and more well-liked. Surgical procedures such as uvulopalatopharyngoplasty (UPPP) or surgically implanted devices like Inspire treatment are also taken into consideration in extreme circumstances. Traditional sleep apnea devices face competition from these alternatives as they gain popularity and efficacy, which restricts market expansion and forces producers to develop new products.


CPAP devices lead the market, while pulse oximeters drive diagnostics

Therapeutic Devices have gained a significant share in the market for sleep apnea devices. These devices play a crucial role in managing sleep apnea by providing a consistent and continuous flow of air that keeps the airways open. The effectiveness of CPAP devices in alleviating symptoms and improving sleep quality has contributed to their dominance in the market. CPAP devices are considered a cornerstone of sleep apnea treatment and are at the forefront of addressing the rising global demand for effective therapeutic solutions in sleep medicine.

Pulse oximeters are widely employed for measuring blood hemoglobin oxygen saturation, offering a continuous and relatively non-invasive assessment. Their convenience has made them a ubiquitous tool in hospitals and healthcare settings. The application of pulse oximetry extends to investigating and diagnosing obstructive sleep apnea in adults and children, involving various practices. When incorporated into overnight polysomnograms (PSG), pulse oximeters enable the interpretation of data patterns in conjunction with events in other physiological channels, potentially providing a detailed characterization of pathophysiology. Furthermore, the growing global prevalence of sleep apnea is anticipated to propel this segment's growth throughout the forecast period.


Hospitals, clinics, and sleep laboratories will hold the largest market share

The market for Sleep Laboratories, Clinics & Hospitals is witnessing significant growth as the demand for comprehensive sleep disorder diagnosis and treatment rises. Sleep labs, clinics, and hospitals play a crucial role in addressing conditions like sleep apnea, insomnia, and other sleep-related disorders. These facilities conduct diagnostic tests such as polysomnography to monitor various physiological parameters during sleep. Increasing awareness of the impact of sleep on overall health has led to a surge in patients seeking professional evaluation. The market's growth is further fueled by advancements in sleep medicine, technology, and the adoption of telemedicine for remote patient monitoring, enhancing accessibility to sleep-related healthcare services.


Sleep Apnea Devices Market Overview by Regions

By countries, the global Sleep Apnea Devices market is divided into United States, Canada, Germany, United Kingdom, France, Italy, Spain, Switzerland, Japan, China, India, South Korea, Indonesia, Australia, Mexico, Brazil, Argentina, South Africa, Saudi Arabia, United Arab Emirates, and Rest of World.

United States Sleep Apnea Devices Market
The high prevalence of sleep apnea, especially obstructive sleep apnea (OSA), and growing awareness of its health dangers are driving the rapid expansion of the sleep apnea equipment market in the United States. Although BiPAP machines, adaptive servo-ventilation (ASV), and oral appliances are all becoming more popular, CPAP devices still control the market and provide most patients with effective treatment. The convenience and compliance of patients are being enhanced by technological advancements such quieter versions, portable devices, and connectivity for remote monitoring. The need for sleep apnea therapy is increasing due to factors including the aging population and rising obesity rates. Access to diagnostic and treatment devices is also being improved by favorable reimbursement rules and rising healthcare spending. With advancements improving patient comfort and therapeutic effectiveness, the market is still thriving.
For example, according to data from 2023 released by the National Council on Aging (NCOA), around 3.0% of women and 12.0% of men in the United States between the ages of 30 and 49 suffer from sleep apnea.


Germany Sleep Apnea Devices Market

Due to the high prevalence of sleep apnea, especially obstructive sleep apnea, and the growing emphasis on sleep health, the German market for sleep apnea devices is expanding steadily. Widespread access to sleep apnea diagnosis and treatment is made possible by Germany's strong healthcare system, with CPAP equipment being the most widely utilized treatment option. As alternate therapies to CPAP, BiPAP machines, adaptive servo-ventilation (ASV) equipment, and oral appliances are becoming more and more well-liked. Patient compliance and results are being improved by technological improvements like mobile apps and remote monitoring, as well as by quieter and more comfortable devices. Germany's market is anticipated to continue rising as a result of advantageous reimbursement policies and an emphasis on patient-centered care, as well as increased awareness of the health hazards associated with sleep apnea, particularly cardiovascular consequences.


India Sleep Apnea Devices Market

Due to the increasing prevalence of sleep apnea, especially among the elderly and obese, the market for sleep apnea devices in India is expanding significantly. The need for efficient diagnostic and treatment methods is being driven by growing awareness of the health hazards—such as heart disease and stroke—that untreated sleep apnea poses. Although alternative therapies like BiPAP, adaptive servo-ventilation (ASV), and oral appliances are becoming more popular, CPAP devices still control the majority of the market. Access and compliance are being improved by technological advancements including quieter, portable devices and the expanding availability of sleep testing at home. A larger population in India can now receive sleep apnea treatments thanks to the market's growth, which is fueled by the development of healthcare infrastructure, favorable reimbursement regulations, and growing disposable incomes.


Saudi Arabia Sleep Apnea Devices Market

The market for sleep apnea devices in Saudi Arabia is expanding quickly because to rising awareness of sleep disorders and the health hazards they pose, including diabetes and cardiovascular illnesses. The need for sleep apnea treatments is being further increased by the rise in obesity, a significant risk factor for the condition. The industry is dominated by CPAP devices, but alternative therapies such oral appliances, adaptive servo-ventilation (ASV), and BiPAP machines are becoming more and more well-liked. Patient compliance is increasing as a result of technological developments, such as equipment that are more comfortable and quieter. The development of specialist sleep facilities and government programs to increase access to healthcare are also fueling market expansion. The Saudi Arabian market for sleep apnea devices is anticipated to keep growing as awareness rises and healthcare infrastructure gets stronger.


Types – Market breakup from 2 viewpoints:
1. Therapeutic Devices
2. Diagnostic Devices


Therapeutic Devices – Market have been further sub segmented from 4 viewpoints:
1. CPAP Sleep Apnea Therapeutic Devices
2. Auto CPAP Sleep Apnea Therapeutic Devices
3. BiPAP Sleep Apnea Therapeutic Devices
4. Adaptive Servo-Ventilation (ASV)


Diagnostic Devices – Market have been further sub segmented from 5 viewpoints:
1. Polysomnography Devices(PSG)
2. Oximeter
3. Actigraphy Monitoring Device
4. Respiratory Polygraph
5. Sleep Apnea Screening Device


End User – Market breakup from 2 viewpoints:
1. Sleep Laboratories, Clinics & Hospitals
2. Home Care Settings/Individuals


Country – Market breakup from Company 21 Sleep Apnea Devices Industry
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Spain
2.6 Switzerland
3. Asia – Pacific
3.1 Japan
3.2 China
3.3 India
3.4 South Korea
3.5 Indonesia
3.6 Australia
4. Latin America
4.1 Mexico
4.2 Brazil
4.3 Argentina
5. Middle East & Africa
5.1 South Africa
5.2 Saudi Arabia
5.3 United Arab Emirates
6. Rest of World


All key players have been covered from 3 viewpoints:
• Overview
• Recent Development
• Financial Insight


Company Analysis:
1. Carefusion Corp
2. Somnomed
3. ResMed Inc.
4. Koninklijke Philips N.V.
5. Compumedics Limited (CMP)
6. Nihon Kohden Corporation
7. Natus Medical Incorporated
8. Teleflex Incorporated

ページTOPに戻る

Table of Contents

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges


5. Global Sleep Apnea Devices Market


6. Market Share
6.1 By Products Types

6.1.1 By Therapeutics
6.1.2 By Diagnostics

6.2 By End User
6.3 By Countries


7. Product Types
7.1 Therapeutic Devices

7.1.1 CPAP Sleep Apnea Therapeutic Devices
7.1.2 Auto CPAP Sleep Apnea Therapeutic Devices
7.1.3 BiPAP Sleep Apnea Therapeutic Devices
7.1.4 Adaptive Servo-Ventilation (ASV)

7.2 Diagnostic Devices

7.2.1 Polysomnography Devices (PSG)
7.2.2 Oximeter
7.2.3 Actigraphy Monitoring Device
7.2.4 Respiratory Polygraph
7.2.5 Sleep Apnea Screening Device


8. End User
8.1 Sleep Laboratories, Clinics & Hospitals
8.2 Home Care Settings/Individuals


9. Countries
9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Switzerland

9.3 Asia – Pacific

9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 South Korea
9.3.5 Indonesia
9.3.6 Australia

9.4 Latin America

9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina

9.5 Middle East & Africa

9.5.1 South Africa
9.5.2 Saudi Arabia
9.5.3 United Arab Emirates

9.6 Rest of World


10. Porter's Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threats


12. Key Players Analysis
12.1 Carefusion Corp. (Part of Becton, Disckinson & Company)

12.1.1 Overviews
12.1.2 Recent Development
12.1.3 Revenues

12.2 Somnomed

12.2.1 Overviews
12.2.2 Recent Development
12.2.3 Revenues

12.3 ResMed Inc.

12.3.1 Overviews
12.3.2 Recent Development
12.3.3 Revenues

12.4 Koninklijke Philips N.V.

12.4.1 Overviews
12.4.2 Recent Development
12.4.3 Revenues

12.5 Compumedics Limited (CMP)

12.5.1 Overviews
12.5.2 Recent Development
12.5.3 Revenues

12.6 Nihon Kohden Corporation

12.6.1 Overviews
12.6.2 Recent Development
12.6.3 Revenues

12.7 Natus Medical Incorporated

12.7.1 Overviews
12.7.2 Recent Development
12.7.3 Revenues

12.8 Teleflex Incorporated

12.8.1 Overviews
12.8.2 Recent Development
12.8.3 Revenues